New Treatment Could Help Fix the Heart ’s ‘Forgotten Valve’
Patients with leaking tricuspid valves in a research trial saw improvements with a procedure that does not require a risky open-heart surgery. (Source: NYT Health)
Source: NYT Health - March 4, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Heart Clinical Trials Surgery and Surgeons Medical Devices Research Abbott Laboratories American College of Cardiology Edwards Lifesciences Corporation New England Journal of Medicine your-feed-science your-feed-health Source Type: news
Ultrasound ablation improves motor function in Parkinson's disease patients
Ultrasound ablation potentially improves motor function and reduces dyskinesi...Read more on AuntMinnie.comRelated Reading:
Ultrasound renal denervation helps reduce blood pressure
Contrast helps with echocardiography for aortic valve surgery
CEUS better than MRI for diagnosing liver, kidney tumors
Nomogram predicts venous thromboembolism in glioma patients
PET tracers predict prostate patient response to HIFU (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 1, 2023 Category: Radiology Source Type: news
Medtronic CoreValve/Evolut ™ Demonstrates Best Durability
Medtronic today announced five-year bioprosthetic valve dysfunction (BVD) data for the CoreValve/Evolut ™ platform, the first and only transcatheter aortic valve replacement (TAVR) platform to show significantly better valve performance and durability compared to surgical aortic valve replacement (SAVR) at five years. Data, presented by Dr. Steven Yakubov, in a late-breaking clinical trial session a t the 2023 annual meeting of Cardiovascular Research Technologies (CRT 2023), build upon the excellent results of the structural valve deterioration (SVD) analysis recently published in JAMA Cardiology. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 27, 2023 Category: Cardiology Source Type: news
Contrast helps with echocardiography for aortic valve surgery
A contrast agent should be used to improve the Doppler profile on echocardiograph...Read more on AuntMinnie.comRelated Reading:
AI bests sonographers for assessment of cardiac function
Echocardiographers warned of interventional radiation risk
Contrast shortage drives urgent changes in interventional radiology
Echo links low atrial function to dementia later in life
Echo algorithm can diagnose cardiac dysfunction from cancer therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 24, 2023 Category: Radiology Source Type: news
Scientists are making 3D-printed human HEARTS to finesse valve replacement surgeries
Experts at the Massachusetts Institute of Techonology (MIT) have created a replica of patient's heart that they say can even start to pump like the real thing. (Source: the Mail online | Health)
Source: the Mail online | Health - February 23, 2023 Category: Consumer Health News Source Type: news
Fewer Surprise Bills: Most U.S. Hospitals Now Transparent on Prices
MONDAY, Feb. 20, 2023 -- Shopping for cataract surgery, a heart valve replacement or a colonoscopy?
You ’re better able these days to compare what one hospital charges against the prices at another, according to a new report from the U.S. Centers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 20, 2023 Category: General Medicine Source Type: news
Should Medtronic's Recent Colibri Patent Controversy Concern You?
Why is Russia reopening dormant copper mines? (From Investing Trends) In early February 2023, Medtronic PLC (NYSE: MDT) was found guilty of patent infringement regarding Colibri Heart Valve LLC transcatheter aortic valve replacement system (TAVR). While this is certainly troubling for one of the…#medtronicplc #medtronic #mdt #dublin #ireland #colibri #corevalve #tavr #medtronicsevolut #colibris (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2023 Category: Consumer Health News Source Type: news
New keyhole surgery plan to slash hospital recovery time for patients with heart valve complaints
The operation is designed to cure a condition called aortic valve stenosis, which happens when a crucial valve in the heart narrows and reduces blood flow around the body. (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2023 Category: Consumer Health News Source Type: news
Potential Biases in TAVI Trials Highlighted Potential Biases in TAVI Trials Highlighted
A new meta-analysis of trials comparing TAVI to surgery for aortic valve stenosis highlights a high rate of potential bias in the trials, researchers conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 12, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Heart valve repair company Cardiac Dimensions raises $35M
The Kirkland-based company is growing its 55-person team and working to get its device — already available in Europe and Australia — approved for use in the U.S. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 9, 2023 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news
Black Patients More Likely to Get Riskier Heart Surgeries
WEDNESDAY, Dec. 28, 2022 -- Insured Black patients are less likely to undergo minimally invasive heart valve replacement or repairs -- relatively safe procedures -- than their white counterparts, new research shows.
Black patients who need a mitral... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 28, 2022 Category: General Medicine Source Type: news
Skipping Antiplatelets Altogether Not Such a Bad Idea for Select TAVR Patients
(MedPage Today) -- Following transcatheter aortic valve replacement (TAVR), the optimal antithrombotic regimen for some people may be no antithrombotics at all, according to provocative registry data from Japan.
Compared with the single antiplatelet... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 14, 2022 Category: Urology & Nephrology Source Type: news
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
TAVR at 20: How Much Longer Will Medicare Mandate a Registry?
(MedPage Today) -- As transcatheter aortic valve replacement (TAVR) marked the 20th anniversary this year of the first-in-man use, it also reached its 10th anniversary of coverage by CMS.
But despite the randomized trials proving utility in individuals... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 8, 2022 Category: Urology & Nephrology Source Type: news
AHA News: A Heart Attack During Pregnancy, Then Heart Valve Surgery
WEDNESDAY, Dec. 7, 2022 (American Heart Association News) -- As she walked up to her fourth-floor apartment, Marisa MacDonnell figured something was different with this pregnancy, her second.
She felt winded. She had to take deeper breaths. And... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2022 Category: General Medicine Source Type: news
